Biotech Stock Moves Higher After Fast-Track Designation

SAGE has been struggling on the charts all year

Deputy Editor
Sep 15, 2021 at 1:36 PM
facebook twitter linkedin

SAGE Therapeutics Inc (NYSE:SAGE) is in the spotlight today, after the drugmaker received fast-track designation from the U.S. Food and Drug Administration (FDA) for its potential Huntington's disease treatment. The drug candidate, Sage-718, is expected to start a Phase 2 trial later this year. At last check, SAGE is up 4% to trade at $45.34. 

The stock has been struggling on the charts this year, down 47.6% year-to-date, though the $40 level contained the damage in August . Despite today's pop, the 50-day moving average is keeping a close lid on the shares. 

SAGE 0915

More FDA progression could break the analyst gridlock, with 10 of the 20 in coverage carrying a "hold" rating, with 10 a "strong buy." However, the 12-month consensus price target of $85.11 is an 87.6% premium to current levels, so perhaps price-target hikes won't be coming down the pike so soon.

Elsewhere, the options pits have been more bullish than usual. This is per SAGE's 10-day call/put volume ratio of 9.70 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which stands higher than 88% of readings from the past year. Echoing this, the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.87 stands in the low 7th annual percentile, suggesting short-term options traders have rarely been more call-biased. 

It's also worth noting that SAGE  ranks low on the Schaeffer's Volatility Scorecard (SVS), with a score of just 12 out of 100. In other words, the security has consistently realized lower volatility than the options pits have priced in, making the equity a potential premium-selling candidate.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners